SCHEMBL8360567

SCHEMBL8360567

CCCCN(C)C(=O)CCCCCCCNC(=O)Cc1c(C)n(C(=O)c2ccc(Cl)cc2)c2ccc(OC(C)=O)cc12

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 12/20 0.69
HDAC3 O15379 3/20 0.64
HDAC1 Q13547 3/20 0.64
HDAC8 Q9BY41 3/20 0.64
HDAC6 Q9UBN7 3/20 0.64
HDAC2 Q92769 1/20 0.64
PTGS1 P23219 5/20 0.61
HRH4 Q9H3N8 1/20 0.60
APP P05067 1/20 0.55
BCHE P06276 1/20 0.55
ACHE P22303 1/20 0.55
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA4 P22748 1/20 0.54
CA9 Q16790 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8354849 1.00 PTGS2 (0.69) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8358998 0.93 PTGS2 (0.65) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8359040 0.93 PTGS2 (0.58) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8353891 0.93 PTGS2 (0.81) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8356529 0.93 PTGS2 (0.81) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8356649 0.93 PTGS2 (0.58) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8353578 0.90 PTGS2 (0.68) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8356741 0.89 PTGS2 (0.69) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8356532 0.89 PTGS2 (0.69) PTGS2HDAC3HDAC1HDAC8HDAC6
SCHEMBL8360244 0.88 PTGS2 (0.72) PTGS2HDAC3HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877202-A Indole derivatives useful to treat estrogen-related neoplasms and disorders AVENTISUB II INC. 1999-03-02 US claimed
EP-0746544-B1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMA INC (US) 1998-09-09 EP claimed
EP-0746544-A1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMACEUTICALS INC. (US) 1996-12-11 EP claimed
WO-1995022524-A1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMACEUTICALS INC. (US) 1995-08-24 WO claimed
US-5877202-A Indole derivatives useful to treat estrogen-related neoplasms and disorders AVENTISUB II INC. 1999-03-02 US disclosed
EP-0746544-B1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMA INC (US) 1998-09-09 EP disclosed
EP-0746544-A1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMACEUTICALS INC. (US) 1996-12-11 EP disclosed
WO-1995022524-A1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMACEUTICALS INC. (US) 1995-08-24 WO disclosed